This piece was supported by the eWEAR-TCCI awards for scientific writing commissioned by eWEAR and made possible by funding through eWEAR industrial affiliates program benefactor Shanda Impact Investment LLC and the Tianqiao and Chrissy Chen Institute.

In the AI-driven healthcare innovation landscape, where the production-progress paradox can stall clinical impact, companies like January AI help move science from paper to practice.

In conversation with January AI co-founders Noosheen Hashemi and Michael Snyder, I wrote about how the company is working to improve metabolic health using AI-enhanced digital health interventions built on research from the Snyder Lab.

AI offers a means of anticipating fluctuations in blood sugar levels measured using wearable continuous glucose monitors (CGMs), and January AI is a company leveraging it to do so.

By bridging the worlds of medicine and art, we hoped to showcase the transformative potential of creativity to uplift, inspire, and offer light in times of darkness.

Many thanks to our student & faculty artists and the Stanford Medicine Orchestra!

Chibuike Uwakwe, Chemistry/Biology Interface (CBI) fellow at Sarafan ChEM-H, on the exciting Stanford Chamber Chorale tours this year. @chibuikeuwakwe.bsky.social

Chibuike Uwakwe, Chemistry/Biology Interface (CBI) fellow at Sarafan ChEM-H, on what he learned during his rotation in the Bao Group. @chibuikeuwakwe.bsky.social

Chibuike Uwakwe, Chemistry/Biology Interface (CBI) fellow at Sarafan ChEM-H, on how the brain-computer interface could bring new hope to ALS patients. @chibuikeuwakwe.bsky.social